Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic...
Monday, November 25, 2024 BiopharmaWatch Research 1 min read
Key Takeaway: Spyre Therapeutics, Inc. (NASDAQ: SYRE) is set to participate in the 7th Annual Evercore ISI HealthCONx Conference. The event underscores the company's commitment to showcasing its advancements in antibody engineering and rational therapeutic approaches. Interested parties can access the live webcast through the company's Investor section, with the replay available post-event. This participation highlights Spyre’s efforts to enhance its presence in the biotech community.
Price reaction · baseline $27.7 (2024-11-22 close) · clean, no other SYRE news in the window
day 0 close
+0.4%
Market Sentiment Analysis
POSITIVE FACTORS
Spyre Therapeutics is actively engaging in industry conferences.
The company's focus on antibody engineering demonstrates innovation.
Participation in established conferences can boost visibility and credibility.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+249%
120-day peak, hindsight
Typical move
3.2%
average across 3 past catalysts
Cash runway
~49 mo
Minimal dilution risk
Lead asset
Co-ArgI-PEG modified human arginase I
Phase 2 · Acute Myeloid Leukemia
Full Press Release Details
To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. An archive of the webcast will be available for replay following the end of the conference.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
Frequently Asked Questions
How can I access the Spyre webcast?
Visit the 'Events & Presentations' page in the Investors section on the Spyre website.
Will there be a replay of the webcast?
Yes, an archive of the webcast will be available after the conference.
Where can I follow Spyre Therapeutics?
You can follow them on social media @spyretx and on LinkedIn.
What is the source of this information?
The information is sourced from Spyre Therapeutics, Inc.